Attached files
| file | filename |
|---|---|
| 10-K/A - 10-K/A - Aegerion Pharmaceuticals, Inc. | a16-6090_110ka.htm |
| EX-31.2 - EX-31.2 - Aegerion Pharmaceuticals, Inc. | a16-6090_1ex31d2.htm |
| EX-31.1 - EX-31.1 - Aegerion Pharmaceuticals, Inc. | a16-6090_1ex31d1.htm |
Exhibit 32.1
CERTIFICATIONS PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Aegerion Pharmaceuticals, Inc. (the “Company”) for the fiscal year ended December 31, 2014 as filed with the Securities and Exchange Commission on March 2, 2015 (the “Report”), each of the undersigned officers of the Company hereby certifies, pursuant to 18 U.S.C. (section) 1350, as adopted pursuant to (section) 906 of the Sarbanes-Oxley Act of 2002, that to the best of her or his knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
/s/ Mary T. Szela |
| |
|
Name: |
Mary T. Szela |
|
|
Title: |
Chief Executive Officer (principal executive officer) |
|
|
|
and Director |
|
|
Date: |
March 10, 2016 |
|
|
|
| |
|
/s/ Gregory D. Perry |
| |
|
Name: |
Gregory D. Perry |
|
|
Title: |
Chief Financial and Administrative |
|
|
|
Officer (principal financial officer and principal |
|
|
|
accounting officer) |
|
|
Date: |
March 10, 2016 |
|